Adverse effects of immune checkpoint inhibitor therapies on right ventricular function and pulmonary arterial dilatation

Immunologic risk factors contribute to endothelial dysfunction and development of pulmonary vascular disease. Immune checkpoint inhibitors, used as immunotherapies for malignancies, have a wide range of reported immune-related adverse events. We retrospectively describe the impact of immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mylvaganam, Ruben, Avery, Ryan, Goldberg, Isaac, Makowski, Courtney, Kalhan, Ravi, Villaflor, Victoria, Cuttica, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878999/
https://www.ncbi.nlm.nih.gov/pubmed/33623668
http://dx.doi.org/10.1177/2045894021992236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878999/
https://www.ncbi.nlm.nih.gov/pubmed/33623668
http://dx.doi.org/10.1177/2045894021992236

Ejemplares similares